Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Cannabis Neurobiology And Schizophrenia Risk in Youth: A Multi-Omics Translation

Obiettivo

Schizophrenia is among the most disabling Schizophrenia is one of the most disabling psychiatric disorders with great societal burden, yet its treatment and prevention are stalled by the severe lack of mechanistic understanding. At the same time, cannabis, the most used illicit drug worldwide, is a strong, modifiable risk factor, especially during adolescence when the brain is still maturing. With rapidly increasing use of potent cannabis among youth, uncovering how it disrupts brain development and contributes to schizophrenia risk has become an urgent scientific and public health priority.

CANARY introduces a novel translational framework that bridges neuroscience and psychiatric epidemiology: from mouse to human and from mechanism to clinic.

Aim 1 reveals joint transcriptional and epigenetic disruptions by THC (primary psychoactive component in cannabis), by generating the first temporal, cell-type resolved multi-omics atlas of THC effects in adolescent mouse brain.

Aim 2 maps these molecular signatures to human schizophrenia genomics using advanced cross-species multi-omic integrations, defining THC-schizophrenia shared genes, enhancers, and biological networks.

Aim 3 translates these mechanisms into clinical insight through (i) mechanism-informed individual genetic scores to identify vulnerable subgroups, and (ii) drug repurposing validated in real-world Nordic registry data using target-trial emulation.

CANARY transforms psychiatry from descriptive associations to mechanistic precision. By comprehensively integrating multi-omics and population-scale data, it clarifies how THC affects youth brain and how this can be translated to actionable clinical insights with real-world validation. Amid the accelerating global rise of cannabis use, this multi-modal framework delivers the urgently needed mechanistic foundation to guide targeted prevention and reveal new therapeutic options, establishing a scalable, mechanism-anchored blueprint for precision psychiatry.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-STG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

KAROLINSKA INSTITUTET
Contributo netto dell'UE
€ 1 500 000,00
Indirizzo
NOBELS VAG 5
171 77 STOCKHOLM
Svezia
Regione
Östra Sverige Stockholm Stockholms län
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 500 000,00

Beneficiari (1)